Aptatargets

Aptadir Therapeutics

The company develops RNA inhibitor-based therapeutics that reactivate silenced genes to treat patients with intractable cancers and rare genetic conditions.

TargED Biopharmaceuticals

The company develops targeted biological drugs to treat thrombotic diseases such as acute ischaemic stroke and immune-mediated thrombotic thrombocytopenic purpura for healthcare providers.

Aplagon

This company develops heparin proteoglycan mimetics to treat thrombo-inflammatory diseases in patients with cardiovascular conditions such as chronic limb-threatening ischaemia.

PentaBind

This company develops aptamer-based therapeutics and sensing assets for pharmaceutical and diagnostics companies using a generative artificial intelligence and wet-lab platform.

Acticor Biotech

The company develops glenzocimab, a therapeutic antibody fragment for treating patients with acute ischemic stroke and other thrombotic diseases.

ASHVATTHA THERAPEUTICS

This clinical-stage biopharmaceutical company develops targeted nanomedicine therapeutics for patients with inflammatory, neurological, and ophthalmic diseases including age-related macular degeneration.

Apoxis SA

This company develops therapeutic proteins and small molecules for the treatment of cancer and inflammatory diseases in clinical-stage patients.

AZ Therapies

This biopharmaceutical company develops therapies for neurodegenerative diseases, including Alzheimer's disease and ischaemic stroke, to treat patients and improve their cognitive health.